Activation of c-fos mRNA in the brain by the -opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine

By Panegyres P.K.   Hughes J.  

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist

By Lieberman P.B.   Woods J.H.   Young E.A.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Attenuation of morphine tolerance and dependence with the highly selective -opioid receptor antagonist TIPP[ ]

By Fundytus M.E.   Schiller P.W.   Shapiro M.   Weltrowska G.   Coderre T.J.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 105-108

Elsevier

Access to resources Recommend Favorite

Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned - or -opioid receptors

By Nakagawa T.   Minami M.   Satoh M.  

European Journal of Pharmacology, Vol. 433, Iss. 1, 2001-12 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

Acea-1328, an Nmda Receptor Antagonist, Increases the Potency of Morphine and U50,488h in the Tail Flick Test in Mice

By Lutfy K.   Doan P.   Nugyen M.   Weber E.  

Pharmacological Research, Vol. 38, Iss. 6, 1998-12 ,pp. : 453-460

Academic Press

Access to resources Recommend Favorite